Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available


May 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SRC
  • Price:
  • 79p
“Buy & Build” heavy building materials supplier SigmaRoc’s results were marginally ahead of expectations with sales of £272m and EBITDA £49m  representing year on year growth of 119% and 107% respectively. The main driver was the acquisition of Nordkalk, which was owned from September while there were also contributions from two Belgian bolt-ons. Management also achieved price and volume growth in the core business.The group had a solid start to 2022 and crucially, higher input costs are being recovered through price rises.Liberum says that while the shares have tracked the UK building materials sector, the market has missed many positives: in particular, it highlights  rivals Aggregate Industries, Breedon and CRH generat ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X